Article

Transgenic expression of full-length 2',5'-oligoadenylate synthetase 1b confers to BALB/c mice resistance against West Nile virus-induced encephalitis.

Mouse Functional Genetics, Institut Pasteur, Paris, France.
Virology (Impact Factor: 3.28). 06/2011; 417(1):147-53. DOI: 10.1016/j.virol.2011.05.018
Source: PubMed

ABSTRACT Susceptibility of inbred strains to infection with West Nile virus (WNV) has been genetically associated with an arginine-to-a nonsense codon substitution at position 253 (R253X) in the predicted sequence of the murine 2',5'-oligoadenylate synthetase 1B (OAS1B) protein. We introduced by transgenesis the Oas1b cDNA from MBT/Pas mice carrying the R253 codon (Oas1b(MBT)) into BALB/c mice homozygous for the X253 allele (Oas1b(BALB/c)). Overexpression of Oas1b(MBT) mRNA in the brain of transgenic mice prior and in the time course of infection provided protection against the neuroinvasive WNV strain IS-98-ST1. A 200-fold induction of Oas1b(MBT) mRNA in the brain of congenic BALB/c mice homozygous for a MBT/Pas segment encompassing the Oas1b gene was also efficient in reducing both viral growth and mortality, whereas a 200-fold induction of Oas1b(BALB/c) mRNA was unable to prevent virally-induced encephalitis, confirming the critical role of the R253X mutation on Oas1b activity in live mice.

0 Bookmarks
 · 
156 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Developing treatments aimed at the causes of diseases such as cancer, infections and metabolic, autoimmune and psychiatric disorders requires knowledge of the underlying biological mechanisms. Such knowledge can only be obtained by functional studies in which the disease-relevant tissue and the course of disease are manipulated systematically, e.g., pharmacologically, environmentally or genetically. Experimental models are fundamental for meeting these challenges, and biomedical scientists often select mice as models. However, it is often difficult for the outsider to appreciate the translational value of mouse models. That ‘mice are not humans’ is obvious, but the use of experimental models in biomedical research has a dual function: discovery of basic biological mechanisms and development of new drugs and treatments. In this article, the members of the SYSGENET network recount some seminal studies on mouse models that provided key insights into the biology of human diseases and paved the way for the development of novel therapeutic approaches. SYSGENET represents a network of European scientists who use mouse genetic reference populations (GRPs) to understand complex genetic factors influencing disease phenotypes
    European Journal of HumanGenetics 05/2013; May 1. DOI:10.1038/ejhg.2013.79 · 4.23 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The synthesis of proteins from viral mRNA is the first step towards viral assembly. Viruses are dependent upon the cellular translation machinery to synthesize their own proteins. The synthesis of proteins from the human immunodeficiency virus (HIV) type 1 and 2 RNAs utilize several alternative mechanisms. The regulation of viral protein production requires a constant interplay between viral requirements and the cell response to viral infection. Among the antiviral cell responses, the interferon-induced RNA activated protein kinase, PKR, regulates the cellular and viral translation. During HIV-1 infection, PKR activation is highly regulated by viral and cellular factors. The cellular TAR RNA Binding Protein, TRBP, the Adenosine Deaminase acting on RNA, ADAR1, and the PKR Activator, PACT, play important roles. Recent data show that PACT changes its function from activator to inhibitor in HIV-1 infected cells. Therefore, HIV-1 has evolved to replicate in cells in which TRBP, ADAR1 and PACT prevent PKR activation to allow efficient viral protein synthesis. This proper translation will initiate the assembly of viral particles.
    Virus Research 07/2014; DOI:10.1016/j.virusres.2014.07.014 · 2.83 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: While the role of viral variants has long been known to play a key role in causing variation in disease severity, it is also clear that host genetic variation plays a critical role in determining virus-induced disease responses. However, a variety of factors, including confounding environmental variables, rare genetic variants requiring extremely large cohorts, the temporal dynamics of infections, and ethical limitation on human studies, have made the identification and dissection of variant host genes and pathways difficult within human populations. This difficulty has led to the development of a variety of experimental approaches used to identify host genetic contributions to disease responses. In this chapter, we describe the history of genetic associations within the human population, the development of experimentally tractable systems, and the insights these specific approaches provide. We conclude with a discussion of recent advances that allow for the investigation of the role of complex genetic networks that underlie host responses to infection, with the goal of drawing connections to human infections. In particular, we highlight the need for robust animal models with which to directly control and assess the role of host genetics on viral infection outcomes.
    Advances in Virus Research 01/2014; 88:193-225. DOI:10.1016/B978-0-12-800098-4.00004-0 · 3.59 Impact Factor

Full-text (2 Sources)

Download
19 Downloads
Available from
May 31, 2014